Literature DB >> 28110912

Semaglutide: a promising new glucagon-like peptide-1 receptor agonist.

André J Scheen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28110912     DOI： 10.1016/S2213-8587(17)30012-8

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN： 2213-8587            Impact factor:   32.069


× No keyword cloud information.
  1 in total

1.  Cardiovascular outcomes associated with SGLT-2 inhibitors versus other glucose-lowering drugs in patients with type 2 diabetes: A real-world systematic review and meta-analysis.

Authors:  Chun-Xing Li; Shuo Liang; Lingyan Gao; Hua Liu
Journal:  PLoS One       Date:  2021-02-19       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.